Actively Recruiting
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
Led by Zhongda Hospital · Updated on 2025-02-27
198
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
Z
Zhongda Hospital
Lead Sponsor
E
Eastern Hepatobiliary Surgery Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study focused on exploring new comprehensive treatment strategies for patients with unresectable combined hepatocellular-cholangiocarcinoma, classifying patients with CHC subtypes based on the combination of artificial intelligence and multi-omics, and exploring the optimal treatment strategies for patients with different subtypes, helping clinicians to screen the most beneficial groups of various treatment schemes, and providing new ideas for safe treatment of high-risk patients.
CONDITIONS
Official Title
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older with CHC confirmed by histology or cytology
- Unresectable or metastatic CHC with prior local or systemic therapy and at least one measurable lesion
- Expected survival time of 3 months or longer
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
- Child-Pugh liver function classification A or B
You will not qualify if you...
- Pregnant or lactating women, and men or women of childbearing age unwilling or unable to use effective contraception
- History of other cancers within the past five years unless fully treated and disease-free for five years with low recurrence risk
- Fully treated carcinoma in situ with no evidence of disease
- History of gastrointestinal bleeding or bleeding tendency within six months that prevents study participation
- Major organ or bone marrow transplant within two years before study start, or active autoimmune disease needing systemic therapy
- Other conditions or incomplete data that make participation unsuitable as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongda Hospital
Nanjing, Jiangsu, China
Actively Recruiting
Research Team
G
Gao-Jun Teng, M.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here